Recurrent Fallopian Tube Carcinoma

specific

The reemergence of fallopian tube carcinoma after a period of remission.

81

Centers

389

Active Trials

Cancer Funding

Top Centers for Recurrent Fallopian Tube Carcinoma(81)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.6
2
NCI Comprehensive
High-Volume Research Center
72.6
3
NCI Comprehensive
High-Volume Research Center
71.5
4
High-Volume Research Center
71.5
5
NCI Comprehensive
Active Research Program
69.0
6
NCI Comprehensive
Active Research Program
69.0
7
NCI Comprehensive
Active Research Program
69.0
8
Active Research Program
69.0
9
Active Research Program
69.0
10
Active Research Program
69.0
11
Active Research Program
69.0
12
NCI Comprehensive
Active Research Program
63.7
13
NCI Comprehensive
Active Research Program
63.7
14
NCI Comprehensive
Active Research Program
63.7
15
NCI Comprehensive
Active Research Program
63.7
16
NCI Comprehensive
Active Research Program
63.7
17
NCI Comprehensive
Active Research Program
63.7
18
NCI Comprehensive
Active Research Program
63.7
19
NCI Comprehensive
Active Research Program
63.7
20
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
63.7
21
NCI Comprehensive
Active Research Program
63.7
2263.7
23
Active Research Program
63.7
24
NCI Comprehensive
Active Research Program
57.8
25
Active Research Program
57.8
26
NCI Clinical
Active Research Program
57.8
27
NCI Clinical
Active Research Program
57.8
28
Active Research Program
57.8
29
Active Research Program
57.8
30
Active Research Program
57.8
31
Active Research Program
57.8
32
Active Research Program
57.8
33
NCI Comprehensive
Active Research Program
52.0
34
NCI Comprehensive
Active Research Program
52.0
35
NCI Comprehensive
Active Research Program
52.0
36
NCI Comprehensive
Active Research Program
52.0
37
NCI Comprehensive
Active Research Program
52.0
38
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
52.0
39
NCI Clinical
Active Research Program
52.0
40
NCI Comprehensive
Active Research Program
52.0
41
NCI Comprehensive
Active Research Program
52.0
42
NCI Clinical
Active Research Program
52.0
43
NCI Comprehensive
Active Research Program
52.0
44
NCI Comprehensive
Active Research Program
52.0
45
NCI Comprehensive
Active Research Program
45.6
46
NCI Comprehensive
Active Research Program
45.6
47
NCI Comprehensive
Active Research Program
45.6
48
NCI Comprehensive
Active Research Program
45.6
49
NCI Comprehensive
Active Research Program
45.6
50
NCI Comprehensive
Active Research Program
45.6
51
NCI Comprehensive
Active Research Program
45.6
52
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
45.6
53
Active Research Program
45.6
5445.6
55
Active Research Program
45.6
56
NCI Comprehensive
Active Research Program
40.3
57
NCI Comprehensive
Active Research Program
40.3
58
NCI Comprehensive
Active Research Program
40.3
59
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
40.3
60
Active Research Program
40.3
61
NCI Comprehensive
Active Research Program
40.3
62
Active Research Program
40.3
63
Active Research Program
40.3
64
NCI Comprehensive
Active Research Program
35.9
65
NCI Comprehensive
Active Research Program
35.9
66
NCI Comprehensive
Active Research Program
35.9
67
NCI Comprehensive
Active Research Program
35.9
68
NCI Basic_laboratory
Active Research Program
35.9
69
Active Research Program
35.9
70
Active Research Program
35.9
71
Active Research Program
35.9
72
NCI Comprehensive
Contributing Research Center
31.2
73
NCI Comprehensive
Contributing Research Center
31.2
74
NCI Comprehensive
Contributing Research Center
31.2
75
NCI Comprehensive
Contributing Research Center
31.2
76
NCI Clinical
Contributing Research Center
31.2
77
Contributing Research Center
31.2
78
Contributing Research Center
31.2
79
Contributing Research Center
31.2
80
BC CancerVancouver, BC
Contributing Research Center
31.2
81
NCI Comprehensive
28.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →